DCC-3084, DCC-3084
DCC-3084-01-001
Phase 2 small_molecule active
Quick answer
DCC-3084, DCC-3084 for Solid tumors driven by the MAPK Pathway is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Solid tumors driven by the MAPK Pathway
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active